Compound ID | 1777
Class: Antimicrobial peptide
| Agent Type: | Synthetic; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Lipopolysaccharide synthesis inhibitor. Targets outer-membrane proteins |
| Target Pathogen: | Active against Enterobacteriaceae and non-fermenters |
| Description: | Synthetic compound; cyclic peptide-like molecules that mimic secondary structures of proteins; an antimicrobial peptidomimetic |
| Institute where first reported: | Polyphor (now Spexis) |
| Year first mentioned: | 2018 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |